Related Experiment Video
Updated: Feb 11, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Long non-coding RNA SNHG14 contributes to gastric cancer development through targeting miR-145/SOX9 axis
Zhao Liu1, Yan Yan2,3, Sizhe Cao4
1Department of Surgery, Xi'an Chest Hospital, Xi'an TB&Thoracic Tumor Hospital, Xi'an, Shanxi, China.
Abstract:
This study aimed to elucidate the roles of long non-coding RNA SNHG14 in gastric cancer development. LncRNA SNHG14 was markedly up-regulated in gastric cancer tissues and cells. Knockdown of SNHG14 significantly inhibited SGC-7901 cell viability, migration, invasion, and promoted cell apoptosis. In addition, miR-145 was negatively regulated by SNHG14 and the effects of SNHG14 knockdown on cell viability, apoptosis, migration, invasion, and the expression of apoptosis-related proteins and EMT-markers were reversed by inhibition of miR-145 at the same time. Furthermore, SOX9 was verified as a functional target of miR-145, and miR-145 regulated tumor malignant behaviors through regulating SOX9. Besides, knockdown of SNHG14 inhibited the expression of p-PI3 K, p-AKT, and p-mTOR and promoted PTEN expression, where miR-145 inhibition had opposite effects. Moreover, the activated PI3 K/AKT/mTOR pathway caused by miR-145 inhibition was counteracted after knockdown of SOX9. Our findings indicate that up-regulation of lncRNA SNHG14 may contribute to gastric cancer development via targeting miR-145/SOX9 axis and involving in PI3 K/AKT/mTOR pathway. SNHG14-miR-145/SOX9 axis may be a promising therapeutic strategy for gastric cancer treatment.
Insights
Long non-coding RNA SNHG14 promotes gastric cancer by targeting the miR-145/SOX9 axis and PI3K/AKT/mTOR pathway. Inhibiting SNHG14 offers a potential therapeutic strategy for gastric cancer treatment.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Gastric cancer remains a significant global health challenge.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer progression.
- The specific involvement of SNHG14 in gastric cancer pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the functional role of lncRNA SNHG14 in gastric cancer.
- To identify the molecular mechanisms underlying SNHG14's contribution to gastric cancer development.
- To explore the potential of targeting the SNHG14 pathway for gastric cancer therapy.
Main Methods:
- Quantitative real-time PCR to assess SNHG14 expression levels.
- Cell viability, migration, invasion, and apoptosis assays in gastric cancer cells.
- Western blotting to analyze protein expression related to apoptosis, EMT, and the PI3K/AKT/mTOR pathway.
- Luciferase reporter assays to confirm interactions between SNHG14, miR-145, and SOX9.
Main Results:
- SNHG14 was significantly upregulated in gastric cancer tissues and cells.
- Knockdown of SNHG14 inhibited cell viability, migration, and invasion, while promoting apoptosis.
- SNHG14 negatively regulated miR-145, which in turn targeted SOX9, influencing the PI3K/AKT/mTOR pathway.
Conclusions:
- Up-regulation of lncRNA SNHG14 promotes gastric cancer development.
- The SNHG14/miR-145/SOX9 axis plays a crucial role in gastric cancer progression.
- Targeting the SNHG14-miR-145/SOX9 axis represents a potential therapeutic strategy for gastric cancer.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
Targeted Cancer Therapies
There are several types of targeted therapies against...
Hypothalamic-Pituitary Axis
RNA Splicing
Binet's Contribution to Measures of Intelligence
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...

